{"id":335566,"date":"2019-10-08T02:00:00","date_gmt":"2019-10-08T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/focus-sur-les-therapies-innovantes-contre-le-cancer\/"},"modified":"2019-10-08T02:00:00","modified_gmt":"2019-10-08T00:00:00","slug":"focus-sur-les-therapies-innovantes-contre-le-cancer","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/focus-sur-les-therapies-innovantes-contre-le-cancer\/","title":{"rendered":"Focus sur les th\u00e9rapies innovantes contre le cancer"},"content":{"rendered":"<p><strong>Les cellules CAR-T constituent l&#8217;un des d\u00e9veloppements les plus passionnants de l&#8217;immunoth\u00e9rapie \u00e0 l&#8217;heure actuelle. Elle combine l&#8217;immunoth\u00e9rapie, la th\u00e9rapie cellulaire et la th\u00e9rapie g\u00e9nique et pourrait devenir un traitement de routine \u00e0 l&#8217;avenir.<\/strong><\/p>\n<p> <!--more--> <\/p>\n<p>La th\u00e9rapie par cellules CAR-T \u00e9tait l&#8217;un des th\u00e8mes principaux du congr\u00e8s et a fait l&#8217;objet d&#8217;intenses discussions. Les experts se sont accord\u00e9s \u00e0 dire qu&#8217;elle repr\u00e9sente actuellement l&#8217;un des d\u00e9veloppements les plus passionnants en h\u00e9matologie. Outre le d\u00e9veloppement scientifique, qui n&#8217;en est qu&#8217;\u00e0 ses d\u00e9buts et qui n&#8217;est pas encore achev\u00e9 en termes d&#8217;indications, c&#8217;est surtout le financement qui constitue un d\u00e9fi. La question est de savoir comment rendre cette th\u00e9rapie, pourtant tr\u00e8s co\u00fbteuse, accessible aux personnes concern\u00e9es en la faisant prendre en charge par les caisses d&#8217;assurance maladie. Plusieurs r\u00e9unions ont permis de d\u00e9velopper des strat\u00e9gies, comme l&#8217;id\u00e9e de cr\u00e9er un registre pour faire progresser cette th\u00e9rapie efficace.<\/p>\n<p>&nbsp;<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\" size-full wp-image-12404\" alt=\"\" src=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2019\/10\/kasten_oh4_s26.png\" style=\"height:748px; width:400px\" width=\"766\" height=\"1433\"><\/p>\n<p>&nbsp;<\/p>\n<p>Actuellement, la th\u00e9rapie par cellules CAR-T est principalement utilis\u00e9e pour traiter les lymphomes non hodgkiniens \u00e0 grandes cellules (lymphomes \u00e0 cellules B). La forme la plus courante de lymphome non hodgkinien repr\u00e9sente 40% de tous les cas. Mais la leuc\u00e9mie aigu\u00eb lymphoblastique \u00e0 cellules B (LAL) &#8211; du moins jusqu&#8217;\u00e0 l&#8217;\u00e2ge de 25 ans &#8211; peut \u00e9galement \u00eatre trait\u00e9e. En Europe, environ 80% des cas de leuc\u00e9mie infantile sont des ALL. Les besoins sont donc importants. Le traitement par cellules CAR-T combine trois formes de th\u00e9rapie innovantes &#8211; l&#8217;immunoth\u00e9rapie, la th\u00e9rapie cellulaire et la th\u00e9rapie g\u00e9nique. L&#8217;objectif est d&#8217;identifier les cellules tumorales en tant que telles et de pouvoir les combattre gr\u00e2ce \u00e0 des cellules T g\u00e9n\u00e9tiquement modifi\u00e9es. Les scientifiques s&#8217;accordent \u00e0 dire que la th\u00e9rapie par cellules CAR-T a le potentiel de devenir un traitement de routine. C&#8217;est pourquoi la premi\u00e8re r\u00e9union CAR-T a eu lieu en juin \u00e0 Paris. Vous trouverez des informations plus d\u00e9taill\u00e9es sur : www.cartcellnet.org.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-size:11px\"><em><sup>24e<\/sup> Congr\u00e8s de l&#8217;Association europ\u00e9enne d&#8217;h\u00e9matologie (EHA) 2019<\/em><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Sources :<\/p>\n<ol>\n<li>Abken H : CAR-T cells : Comment les cellules immunitaires de conception peuvent \u00eatre arm\u00e9es contre le cancer. Trillium Immunologie 2017 ; 1 : 43-47.  &nbsp;<\/li>\n<li>Tran E, et al : Une \u00e9tape importante pour les CAR T Cells. New Engl J Med 2017. DOI : 10.1056\/NEJMe1714680.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><em>InFo ONKOLOGIE &amp; H\u00c4MATOLOGIE 2019 ; 7(4) : 26 (publi\u00e9 le 20.9.19, ahead of print)<\/em><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les cellules CAR-T constituent l&#8217;un des d\u00e9veloppements les plus passionnants de l&#8217;immunoth\u00e9rapie \u00e0 l&#8217;heure actuelle. Elle combine l&#8217;immunoth\u00e9rapie, la th\u00e9rapie cellulaire et la th\u00e9rapie g\u00e9nique et pourrait devenir un traitement&hellip;<\/p>\n","protected":false},"author":7,"featured_media":91293,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Cellules CAR-T","footnotes":""},"category":[11417,11373,11389,11535,11549],"tags":[13586,20832,27580],"powerkit_post_featured":[],"class_list":["post-335566","post","type-post","status-publish","format-standard","has-post-thumbnail","category-genetique","category-hematologie","category-oncologie","category-rapports-de-congres","category-rx-fr","tag-immunotherapie-fr","tag-leucemie","tag-therapie-par-les-cellules-car-t","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-12 12:16:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":335571,"slug":"focus-sulla-terapia-antitumorale-innovativa","post_title":"Focus sulla terapia antitumorale innovativa","href":"https:\/\/medizinonline.com\/it\/focus-sulla-terapia-antitumorale-innovativa\/"},"pt_PT":{"locale":"pt_PT","id":335440,"slug":"foco-na-terapia-inovadora-do-cancro","post_title":"Foco na terapia inovadora do cancro","href":"https:\/\/medizinonline.com\/pt-pt\/foco-na-terapia-inovadora-do-cancro\/"},"es_ES":{"locale":"es_ES","id":335420,"slug":"centrarse-en-la-terapia-innovadora-del-cancer","post_title":"Centrarse en la terapia innovadora del c\u00e1ncer","href":"https:\/\/medizinonline.com\/es\/centrarse-en-la-terapia-innovadora-del-cancer\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/335566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=335566"}],"version-history":[{"count":0,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/335566\/revisions"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=335566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=335566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=335566"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=335566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}